Zhengye Biotechnology Holding Limited

NASDAQ:ZYBT

Drug Manufacturers - Specialty & Generic

Healthcare
$1.50 +1047.56%

+$7.31 today

Market cap
$71.09M
Beta
-2.17
P/E (TTM)
-36.3
EPS (TTM)
-$1.50
52W Low $0.62High $13.08

Volume 0.02M

Average 0.10M

ZYBT Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Zhengye Biotechnology Holding LimitedNASDAQ: ZYBT

Weighted Avg Shares (Diluted) · Q4 FY2025 · quarter ended Dec 2025

Weighted avg shares (diluted) of 47.39M shares in Q4 FY2025

Q4 FY2025 weighted avg shares (diluted) was 47.39M shares. Over 3 fiscal years it compounded at +0.1% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
47.39M+0.0% QoQ
Last fiscal yearDec 2025
47.35M+0.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+0.4%——
3-year CAGR+0.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
47.35M CNY
Year-over-year change
+0.4%
4-year CAGR
+0.1%

Weighted Avg Shares (Diluted) vs competitors

How ZYBT compares with its peers on the latest reported figures

  • ZYBT's FY2025 weighted avg shares (diluted) of 47.35M shares is the 4th highest of the 9 companies compared; the peer median is 25.37M shares.
  • Its year-over-year change of +0.4% is the 8th highest of 9, against a peer median of +21.8%.
  • Over three fiscal years its annual growth of +0.1% compares with a peer median of +9.3%.
ZYBT Competitors Peer median
Weighted Avg Shares (Diluted) for ZYBT and competitors
Company Period LTM YoY 3-year CAGR
ONCYOncolytics Biotech Inc.LTM Mar 2026100.12M +27.6%+18.2%
CRDLCardiol Therapeutics Inc.LTM Mar 202694.16M +29.4%+11.6%
SERASera Prognostics, Inc.LTM Mar 202649.71M +39.7%+15.5%
ZYBTZhengye Biotechnology Holding LimitedFY202547.35M +0.4%+0.1%
APYXApyx Medical CorporationLTM Mar 202641.45M +15.9%+6.9%
SRZNSurrozen, Inc.LTM Mar 20269.29M +179.8%+47.8%
EXOZeXoZymes, Inc.LTM Mar 20268.4M +2.6%+1.0%
TILInstil Bio, Inc.LTM Mar 20266.73M +3.3%+1.0%
PDEXPro-Dex, Inc.LTM Mar 20263.32M -1.3%-3.7%
Peer median (excluding ZYBT) 25.37M+21.8%+9.3%

Competitors are the stored peer set for ZYBT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue214.07M260.27M211.65M186.36M116.36M
Cost of Revenue88.67M106.75M81.8M95.06M92.49M
Gross Profit125.39M153.52M129.86M91.3M23.87M
Gross Margin58.6%59.0%61.4%49.0%20.5%
Research & Development11.37M13.42M11.9M12.79M18.01M
Selling, General & Admin58.19M63.56M66.63M63.84M74.92M
Operating Expenses73.01M87.69M84.87M74.86M92.12M
Depreciation & Amortization16.01M18.8M23.91M24.16M25.96M
EBITDA70.12M85.55M72.1M42.6M(42.52M)
EBITDA Margin32.8%32.9%34.1%22.9%-36.5%
Operating Income52.38M65.83M44.99M16.44M(68.25M)
Operating Margin24.5%25.3%21.3%8.8%-58.7%
Interest Income112K114K312K231K96K
Interest Expense1.05M2.84M4.42M4.04M3.4M
Other Income / Expenses683K(1.92M)(1.22M)(2.05M)(3.62M)
Income Before Tax53.07M63.91M43.76M14.39M(71.87M)
Pre-Tax Margin24.8%24.6%20.7%7.7%-61.8%
Income Tax Expense6.6M8.17M6.25M924K11.1M
Net Income38.96M46.74M31.46M11.31M(69.78M)
Net Margin18.2%18.0%14.9%6.1%-60.0%
EPS (Basic)0.851.020.690.24(1.40)
EPS (Diluted)0.830.990.670.24(1.40)
Weighted Avg Shares45.67M45.67M45.67M47.17M47.35M
Weighted Avg Shares (Diluted)47.17M47.17M47.17M47.17M47.35M

Zhengye Biotechnology Holding Limited

NASDAQ:ZYBT

Intrinsic Alpha fair value

Locked

Current Price

$1.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.